SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Dunlap who wrote (3768)12/16/1997 4:54:00 PM
From: blankmind  Read Replies (1) of 23519
 
Stockholders' equity: Common stock; $.001 par value; shares
authorized 200,000,000; shares outstanding --
September 30, 1997, 33,149,729; December 31, 1996,
32,454,340(1);............................................... 33 32
Paid in capital.................................................. 159,347 156,173
Less treasury stock,at cost; 185,000 shares at September 30,
1997; none at December 31, 1996............................... (4,184) --
Unrealized gain on securities.................................... 64 77
Deferred compensation............................................ (65) (348)
Accumulated deficit.............................................. (35,383) (66,154)
--------- ---------
Total stockholders' equity............................... 119,812 89,780
--------- ---------
Total.................................................... $ 148,194 $ 96,532
=========
Not sure how this is going to look, but if you take "total equity divided by # of shares," you get:

$119,812,000/33,149,729 = $3.61 per share of book value

Out.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext